Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients

Human Reproduction

Volumn 30, Issue 9, 2015, Pages 2184-2189

  Goldrat, O ^a,b   Gervy, C ^a   Englert, Y ^a,b   Delbaere, A ^a,b   Demeestere, I ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

breast cancer; fertility preservation; letrozole; luteal phase; progesterone

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; PROGESTERONE; RECOMBINANT FOLLITROPIN; AROMATASE INHIBITOR; GONADORELIN; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HORMONE DETERMINATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEOLYSIS; OBSERVATIONAL STUDY; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL; ANTAGONISTS AND INHIBITORS; BLOOD; BREAST TUMOR; COMPARATIVE STUDY; DRUG EFFECTS; PROCEDURES;

ADULT; AROMATASE INHIBITORS; BREAST NEOPLASMS; ESTRADIOL; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; NITRILES; OVULATION INDUCTION; PROGESTERONE; SPERM INJECTIONS, INTRACYTOPLASMIC; TRIAZOLES;

EID: 84940741936     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev155     Document Type: Article

References (23)

1. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008; 26: 2630-2635
2. Bhatnagar AS. The discovery and mechanism of action of letrozole. Breast Cancer Res Treat 2007; 105(Suppl 1): 7-17
3. Bockstaele L, Tsepelidis S, Dechene J, Englert Y, Demeestere I. Safety of ovarian tissue autotransplantation for cancer patients. Obstet Gynecol Int 2012; 2012: 495142
4. Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol 2011; 54: 685-695
5. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update 2009; 15: 649-665
6. Demeestere I, Moffa F, Peccatori F, Poirot C, Shalom-Paz E. Multiple approaches for individualized fertility protective therapy in cancer patients. Obstet Gynecol Int 2012; 2012: 961232
7. Diedrich K, Fauser BC, Devroey P, Evian Annual Reproduction Workshop Group 2009. Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online 2011; 22: 232-248
8. Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, Ernst E, Luyckx V, Andersen CY. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 2013; 99: 1503-1513
9. Huggins C, Moon RC, Morii S. Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci U S A 1962; 48: 379-386
10. Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, Dechene J, Ferster A, Veys I, FastrezMet al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod 2014; 29: 1931-1940
11. Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 2013; 34: 130-162
12. Lambertini M, Anserini P, Levaggi A, Poggio F, Del Mastro L. Fertility counseling of young breast cancer patients. J Thorac Dis 2013; 5: S68-S80
13. Lee S, Oktay K. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer? Fertil Steril 2012; 98: 961-964.e961
14. Lee MC, Gray J, Han HS, Plosker S. Fertility and reproductive considerations in premenopausal patients with breast cancer. Cancer Control 2010; 17: 162-172
15. Lee VC, Chan CC, Ng EH, Yeung WS, Ho PC. Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial. Reprod Biomed Online 2011; 23: 380-388
16. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005; 23: 4347-4353
17. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006; 91: 3885-3890
18. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril 2012; 98: 1363-1369
19. Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet 2014; 31: 927-932
20. Roy KK, Baruah J, Singla S, Sharma JB, Singh N, Jain SK, Goyal M. Aprospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci 2012; 5: 20-25
21. Skildum A, Faivre E, Lange CA. Progesterone receptors induce cell cycle progression via activation of mitogen-Activated protein kinases. Mol Endocrinol 2005; 19: 327-339
22. Stanczyk FZ. Steroid hormones. In: Lobo RA, Mishell DR Jr, Paulson RJ, Schoupe D (eds). Mishell's Textbook of Infertility, Contraception, and Reproductive Endocrinology. Malden, MA, USA: Blackwell Science, 1997, 48-51
23. Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozolegonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 2013; 100: 1681-1685.e1681